Targeting Historically Refractory Interfaces: A Partnership Model That Accelerates Drug Discovery Within an Expanded Haystack

Future Medicinal Chemistry - United Kingdom
doi 10.4155/fmc.09.49
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Future Science Ltd

Related search

A Drug Discovery Partnership for Personalized Breast Cancer Therapy

2013English

Zebrafish an Emerging Model for Preclinical Drug Discovery

International Journal of Research in Pharmaceutical Sciences
ToxicologyPharmaceuticsPharmacology
2020English

Drug Discovery Maps, a Machine Learning Model That Visualizes and Predicts KinomeInhibitor Interaction Landscapes

English

Targeting the Proteostasis Network for Mycobacterial Drug Discovery

ACS Infectious Diseases
Infectious Diseases
2018English

Quality Improvement Within an Academic-Community Partnership

SM Journal of Nursing
2015English

Targeting Human Papillomavirus Genome Replication for Antiviral Drug Discovery

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

Air Pouch Model: An Alternative Method for Cancer Drug Discovery

2019English

Platform for Drug Discovery Targeting HMGB1, AGEs-RAGE Response

Folia Pharmacologica Japonica
Pharmacology
2014English

Yeast as a Model System for Drug Discovery

Folia Pharmacologica Japonica
Pharmacology
2005English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy